BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 27235595)

  • 1. CD4(+)B220(+)TCRγδ(+) T cells produce IL-17 in lupus-prone MRL/lpr mice.
    Qiu F; Li T; Zhang K; Wan J; Qi X
    Int Immunopharmacol; 2016 Sep; 38():31-9. PubMed ID: 27235595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
    Yang J; Li Q; Yang X; Li M
    Mol Med; 2015 Apr; 21(1):364-70. PubMed ID: 25902303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
    Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
    Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.
    Hou LF; He SJ; Li X; Yang Y; He PL; Zhou Y; Zhu FH; Yang YF; Li Y; Tang W; Zuo JP
    Arthritis Rheum; 2011 Aug; 63(8):2445-55. PubMed ID: 21484768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of T cell-dependent autoantibody production by a gammadelta T cell line derived from lupus-prone mice.
    Fujii T; Okada M; Craft J
    Cell Immunol; 2002; 217(1-2):23-35. PubMed ID: 12425998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner HL; Kelley VR
    J Immunol; 1999 Dec; 163(12):6884-91. PubMed ID: 10586090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
    Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasculitis in the Palmerston North mouse model of lupus: phenotype and cytokine production profile of infiltrating cells.
    Luzina IG; Knitzer RH; Atamas SP; Gause WC; Papadimitriou JC; Sztein MB; Storrer CE; Handwerger BS
    Arthritis Rheum; 1999 Mar; 42(3):561-8. PubMed ID: 10088780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro.
    Wu H; Lo Y; Chan A; Law KS; Mok MY
    Immunology; 2016 Sep; 149(1):48-61. PubMed ID: 27278094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 maintains the survival of interleukin-17
    Li T; Zhou Y; Sun X; Bian Y; Wang K; Guo Q; Wang Q; Qiu F
    Int Immunopharmacol; 2020 Sep; 86():106721. PubMed ID: 32615450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities.
    Aicher WK; Fujihashi K; Taguchi T; McGhee JR; Yamamoto M; Eldridge JH; Gay S; Kiyono H
    Eur J Immunol; 1992 Jan; 22(1):137-45. PubMed ID: 1346108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E; Lenda DM; Kelley VR
    J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
    Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
    J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L; Chen HP; Ma Q
    Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice.
    Rankin AL; Guay H; Herber D; Bertino SA; Duzanski TA; Carrier Y; Keegan S; Senices M; Stedman N; Ryan M; Bloom L; Medley Q; Collins M; Nickerson-Nutter C; Craft J; Young D; Dunussi-Joannopoulos K
    J Immunol; 2012 Feb; 188(4):1656-67. PubMed ID: 22231702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human embryonic mesenchymal stem cells alleviate pathologic changes of MRL/Lpr mice by regulating Th7 cell differentiation.
    Yuan L; Xiao ZT; Huang XZ; Wu MJ; Shi H; Liu AF
    Ren Fail; 2016 Oct; 38(9):1432-1440. PubMed ID: 27416851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the interleukin-2 (IL-2)/IL-2 receptor pathway in MRL/lpr lymphadenopathy: the expanded CD4-8- T cell subset completely lacks functional IL-2 receptors.
    Tanaka T; Nagasaka Y; Kitamura F; Kuida K; Suwa H; Miyasaka M
    Eur J Immunol; 1993 Jun; 23(6):1378-80. PubMed ID: 7684688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGR2 is elevated and positively regulates inflammatory IFNγ production in lupus CD4
    Dai R; Heid B; Xu X; Xie H; Reilly CM; Ahmed SA
    BMC Immunol; 2020 Jul; 21(1):41. PubMed ID: 32646370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.